Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.05
+0.49 (7.47%)
At close: Nov 10, 2025, 4:00 PM EST
7.05
0.00 (0.00%)
After-hours: Nov 10, 2025, 7:30 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $456.98 million as of November 10, 2025. Its market cap has decreased by -53.66% in one year.
Market Cap
456.98M
Enterprise Value
567.70M
1-Year Change
-53.66%
Ranking
Category
Stock Price
$7.05
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $456.98M, an increase of 68.43%. That is a compound annual growth rate of 6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 425.22M | -39.17% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |